M
Medipost Co Ltd
KOSDAQ:078160
Medipost Co Ltd
KOSDAQ:078160
Price:
23 250
KRW
4.73%
Market Closed
Market Cap:
₩911.4B
Relative Value
The Relative Value of one Medipost Co Ltd stock under the Base Case scenario is 5 420.7 KRW. Compared to the current market price of 23 250 KRW, Medipost Co Ltd is Overvalued by 77%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
5 420.7
KRW
Overvaluation 77%
M
Multiples Across Competitors
Competitors Multiples
Medipost Co Ltd Competitors
Medipost Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
M
|
Medipost Co Ltd
KOSDAQ:078160
|
908.7B KRW | 12.3 | -9.3 | -14.7 | -13.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
92.8B USD | 0.2 | 52.5 | 13.6 | 13.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.4B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.7B USD | 0.3 | 11.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.9B EUR | 1.1 | 20.1 | 9.5 | 14.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.5B EUR | 1.2 | 23.3 | 9 | 16.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 24.9 | 12 | 17.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 1.9 | 21.7 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.2 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 11.6 | -27.4 | -30 | -27.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.7 | 13.7 | 7.1 | 9.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
